Emeryville, California, United States Santen Pharmaceutical is the famous Corporate Investor, which was founded in 1890. The venture was found in North America in United States. The main department of described Corporate Investor is located in the Emeryville.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Santen Pharmaceutical, startups are often financed by Hatteras Venture Partners, GRA Venture Fund, LLC, Tech Coast Angels. The meaningful sponsors for the fund in investment in the same round are Hatteras Venture Partners, Saints Capital, RMI Partners. In the next rounds fund is usually obtained by Virginia Tech Carilion (VTC) Innovation Fund, Pharmstandard, Rock Springs Capital.
The top activity for fund was in 2015. The higher amount of exits for fund were in 2016. The fund is generally included in less than 2 deals every year. This Santen Pharmaceutical works on 21 percentage points more the average amount of lead investments comparing to the other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. Speaking about the real fund results, this Corporate Investor is 13 percentage points more often commits exit comparing to other organizations.
The fund has exact preference in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline InnFocus Inc, RetroSense Therapeutics, Clearside Biomedical For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Medical, Therapeutics.
The current fund was established by Kenkichi Taguchi.
Related Funds
| Fund Name | Location |
| Blueprint Capital Advisors | New York, New York, United States |
| Cyber Wisdom | China, Hong Kong, Kowloon |
| Decide4action | Greenville, South Carolina, United States |
| Fairstead | New York, New York, United States |
| Fuda Shengwu | China, Zhejiang, Zhuji |
| GAN | England, London, United Kingdom |
| Gateway Partners | Central, Central Region, Singapore |
| Global Life Science Ventures | Bayern, Germany, München |
| Goodworks Ventures | Missoula, Montana, United States |
| Guanhui Shiji | Beijing, Beijing, China |
| Hidashin Innovation Partners | - |
| ID Capital | Central, Central Region, Singapore |
| Lerner Enterprises | Maryland, Rockville, United States |
| Mingyin Guoji Ziben Touzi | Beijing, Beijing, China |
| mortonsgroup | Nebraska, United States, Virginia |
| Norselab | Norway, Oslo |
| Teda Venture Capital | China, Guangdong, Tianjin |
| Tianjin Deya Touzi | - |
| YFY Biotech Management Company | Taipei, Taiwan |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
InnFocus Inc | $33M | 23 Dec 2015 | Miami, Florida, United States | ||
RetroSense Therapeutics | $6M | 12 Nov 2015 | Ann Arbor, Michigan, United States | ||
| $3M | 09 Nov 2015 | Virginia, United States | |||
Clearside Biomedical | $16M | 02 Sep 2014 | Georgia, United States | ||
Clearside Biomedical | $7M | 12 Feb 2013 | Georgia, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
InnFocus Inc | $33M | 23 Dec 2015 | Miami, Florida, United States | ||
RetroSense Therapeutics | $6M | 12 Nov 2015 | Ann Arbor, Michigan, United States | ||
| $3M | 09 Nov 2015 | Virginia, United States | |||
Clearside Biomedical | $16M | 02 Sep 2014 | Georgia, United States | ||
Clearside Biomedical | $7M | 12 Feb 2013 | Georgia, United States |
